Literature DB >> 23941592

Combined blue nevus-smooth muscle hamartoma: a series of 12 cases.

Julia Tzu1, Chloe Goldman, Ann E Perry, Shane A Meehan.   

Abstract

BACKGROUND: One of the most common types of combined melanocytic nevus is that of a blue nevus with ordinary melanocytic nevus. Blue nevi have also been described in association with non-melanocytic cell types, such as those of neural or mesenchymal derivation. Although there are rare descriptions in the literature of blue nevi with myomatous structures, the specific association of combined blue nevi with smooth muscle hyperplasia has not been reported
METHODS: We review the clinicopathological features of 12 cases of combined blue nevi with smooth muscle hyperplasia.
RESULTS: The majority of these lesions occurred on the back of middle-aged patients and were clinically interpreted as melanocytic nevi or melanoma. Histopathologic examination revealed a combined population of 'common' and blue nevus melanocytes with accompanying smooth muscle hyperplasia. In addition to a lentiginous proliferation of melanocytes at the dermal-epidermal junction with variable basilar hyperpigmentation, there were varying degrees of epidermal acanthosis and follicular induction (three cases).
CONCLUSION: We present an unusual hamartoma with features of combined blue nevus and smooth muscle hyperplasia, which has not been previously described.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  blue nevus; combined nevus; hamartoma; melanocytic nevus; smooth muscle

Mesh:

Year:  2013        PMID: 23941592     DOI: 10.1111/cup.12200

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  1 in total

1.  Bilateral Nipple Enlargement as a Secondary Effect of Anabolic Drugs: A Histopathological Mimicker of Smooth Muscle Hamartoma.

Authors:  Mar Llamas-Velasco; Maria Francesca Bianciardi Valassina; Enrique Ovejero-Merino; Guido Massi; Thomas Mentzel
Journal:  Dermatopathology (Basel)       Date:  2021-04-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.